Assistant Practice Manager Kelli Vogt, of Polsloe Veterinary Clinic in Exeter, Devon, has won the 'Petplan Insurance Advisor Award 2010'.
The award, announced last weekend at the British Veterinary Nursing Congress in Kettering, recognises the hard work and dedication that Petplan Insurance Advisors do to highlight the importance of insurance to pet owners.
Kelli said: "It was such a surprise to actually win the award, I'm greatly honoured! The scheme is such a great programme and I recommend it to all my colleagues and anyone that will listen. It's a great link between veterinary practices and insurers and it means that we can really help pet owners have financial security should anything happen. The more pet owners are informed of the importance of pet insurance the more likely it'll become mandatory, which will allow them to always get the best possible treatment for their pet without having to worry about the financial implications."
The finalists were judged by President of BVNA Donna Lewis, Petplan Business Developers Lisa Allen and Spencer Jones, and Head of Business Development at Petplan Howard Brown.
Howard said: "At Petplan we are proud to recognise the dedication and hard work that Pet Insurance Advisors put in to give their customers informed and up-to-date advice. It is great to see the dedication and competence that Kelli has applied to providing her customers with this service, she is a testament to this and she is a very deserving winner."
The other finalists were Wendy Wears, Vet Nurse at Moor Cottage Veterinary Hospital in Berkshire, and Vickie Sadler, Orwell Veterinary Group in Ipswich, Suffolk.
For information on how to become a PIA contact Vetline on 0800 316 8800 or alternatively log onto petplanPIA.co.uk.
To find out more about Petplan visit www.petplan.co.uk
Stephen has been an elected member of RCVS Council since 2012, having previously been an appointed member of Council representing the Royal Veterinary College between 2001 and 2009.
In 2016 he was re-elected to Council to serve a further four-year term and currently chairs the Legislation Working Party.
Stephen graduated from Cambridge in 1980 and subsequently spent time as a large animal practitioner. After undertaking further training in equine surgery and diagnostic imaging at the University of Liverpool, he studied for a PhD at the Royal Veterinary College (RVC) before returning to Liverpool as a Lecturer in Equine Orthopaedics.
He went back to the RVC in 1993 to concentrate on equine clinical services and, in 1997, became Head of the Farm Animal and Equine Clinical Department. He was appointed the RVC’s Vice-Principal for Teaching from 2000 to 2013, Deputy Principal from 2013 to 2017 and currently holds the post of Senior Vice-Principal.
Addressing the need for a learning culture in his speech Stephen said: "Veterinary graduates have never had greater knowledge and technical skills than those graduating this year. But this can make their job so much harder when the certainty of scientific knowledge is confronted with the uncertainties of the sick animal, and the increasing number of possibilities for treatment have to be weighted alongside ethical and economic considerations.
"Of his age, but also prophetic of our age, the philosopher Bertrand Russell commented that 'habits of thought cannot change as quickly as techniques with the result that as skill increases, wisdom fails'.
"So it is important that our young professionals are well-prepared in terms of professional, non-technical skills to cope with the sheer variety of challenges that they encounter, and we, as a profession, within our professional model, provide a nurturing learning culture rather than the blame and cover-up culture that the current emphasis on external regulation fosters, so pervasively and distressingly."
Stephen added that his other priorities would be working with the British Veterinary Association and other stakeholders to uphold the College’s first Brexit principle that 'vital veterinary work continues to get done', a project on graduate outcomes, which flows from the Vet Futures project, and the Legislation Working Party.
The AHT has secured an award of £580,000 from the Wellcome Trust to fund the development of a new diagnostic test for Strangles which takes only 30 minutes.
It's been achieved in part by 'Breaking the Strangles Hold' - a two-year fundraising campaign run by the Animal Health Trust (AHT) and The British Horse Society (BHS),
Money donated from the general public, along with funding from The Horse Trust, has already allowed scientists at the AHT to develop a diagnostic blood test which gives results in 24 hours. The blood test was launched in February 2008 and since then more than 6,700 samples have been tested.
HRH The Princess Royal, who launched the 'Breaking the Strangles Hold' campaign, said: "As an owner who has seen my own horse's affected by this terrible disease, it's wonderful to see such progress being made in a relatively short time.
"The screening test enables owners to know within 24 hours if any of their horses have been exposed to this bacterium. Previously available tests would have taken three to four days. The test is making a real difference in welfare and economic terms for all those involved in the equine industry. It truly is groundbreaking."
The success of this diagnostic work, along with other AHT research, has attracted further funding for the project from the Wellcome Trust in the form of a £580,000 Translation Award.
Professor Andrew Waller, Head of Bacteriology at the AHT, said: "The main problem with Strangles is the time taken to diagnose it. The current blood test is a big step forward, but the culture and DNA tests, which are often used in the initial stages of an outbreak can take a couple of days to get results."
The Translation Award means the AHT can reduce the time taken to perform its DNA diagnostic test and ultimately produce a point-of-care test that vets can use on site to get a diagnosis in 30 minutes. Earlier diagnosis will allow owners to isolate horses sooner and minimise the spread of infection. It will further reduce welfare problems for horses and the cost to their owners.
The AHT and Atlas Genetics will design and validate the point-of-care diagnostic test over the next two years. It is hoped that the test could be mass produced and widely available by 2012.
Professor Waller added: "This technology will be fantastic. It will be hugely beneficial for other diseases too, of both veterinary and clinical importance. Without the money raised through the 'Breaking the Strangles Hold' campaign, we wouldn't have made as much progress. On behalf of horses and horse owners worldwide, I'd like to thank everyone who has donated."
The 'Breaking the Strangles Hold' campaign reached its fundraising target of £250,000 in just two years, demonstrating how important to horse owners it is to get to grips with this terrible disease.
For more information, see: http://www.strangles.org
The epidemic of respiratory disease in early 2010 was characterised by coughing and nasal discharge.
The disease spread through the population of 77,000 Icelandic horses within weeks, leading to a self-imposed ban on their export and significant economic cost to the country.
Initially, due to the speed at which the disease had spread, a viral cause was suspected. However, investigations by researchers at the University of Iceland showed that only Streptococcus zooepidemicus was consistently recovered from coughing horses and rare fatal cases of infection. However, this bacterium is also often found in healthy horses.
The AHT and the Wellcome Trust Sanger Institute were brought in to investigate. Dr Simon Harris from the Wellcome Trust Sanger Institute said: "To identify the culprit, we sequenced the DNA from 257 samples of bacteria from diseased animals and people. This showed that one specific strain of S. zooepidemicus, called ST209, was the likely culprit, and we also found this strain in a human case of blood poisoning. This study highlights, for the first time, how DNA sequencing can be used to identify endemic strains of bacteria and distinguish them from the cause of an epidemic infection."
Iceland is free of all major equine infectious diseases thanks to the ban on the importation of horses into the country in 1882. Consequently, Icelandic horses are particularly susceptible to any new bacteria or virus that crosses the border, and so strict biosecurity regulations are in place to help protect them.
Dr. Sigríður Björnsdóttir of the MAST Icelandic Food and Veterinary Authority, used information from owners and veterinary surgeons to build an epidemiological network. This enabled her to identify an equine rehabilitation centre where horses exercised in a water treadmill. The water treadmill is thought to have provided the perfect conditions for transmitting the disease as water was splashed up and ingested. Horses would complete their rehabilitation and return home, whilst incubating the disease, taking the infection with them.
The ST209 strain of S. zooepidemicus found in Iceland has also been recovered from a coughing horse in Sweden and an abdominal abscess in a Finnish horse trainer.
Dr Andrew Waller, Head of Bacteriology at the AHT, said: "There are a couple of theories as to how the strain entered Iceland. These bacteria are able to survive outside a horse for a week or so, which means the import of contaminated equipment or clothing is the most likely route by which ST209 entered Iceland. However, this particular strain could have even infected a human who travelled to Iceland, before spreading the strain back to a horse and triggering the epidemic.
"We are delighted to have helped uncover the likely identity of the cause of this epidemic. Our investigation highlights the ability of S. zooepidemicus strains to cause disease in animals and people. We found evidence that even endemic strains of S. zooepidemicus were likely causing cases of respiratory disease in Icelandic horses, illustrating that this group of bacteria causes more clinical problems in horses than was previously thought. We hope that raising awareness of the cause of this epidemic, and the likely involvement of a water treadmill as a key factor in disease transmission, will encourage veterinarians around the world to improve disease control precautions preventing future epidemics."
Intervet/Schering-Plough Animal Health has launched a new consumer campaign to support the company's joint care supplement, Cosequin.
The campaign centres around a series of paw-tapping internet videos which showcase the perfectly poised paws of dog and cat dance duo, Fred and Ginger, highlighting the importance of good joint health. The videos are available to view at http://www.cosequin-dance.co.uk/
Pet owners are encouraged to purchase Cosequin from vet practices to enter a prize draw to win a photography day with leading animal photographer, Sam Lunt, or one of ten tickets to an upcoming live dancing tour. Posters and in-practice leaflets are also available for vet practices to help drive awareness and encourage uptake.
Sarah-Jane Minter, Marketing Manager for Intervet/Schering-Plough, commented; "We wanted to create a campaign which would support vets in practice and attract the attention of pet owners, especially those who may not have previously thought about the joint health of their pet. With these lighthearted new videos of Fred and Ginger demonstrating everything from the jive to the rumba and an eye-catching print campaign, we certainly expect to grab pet owners' attention!"
ISPAH says that by supporting joint condition and maintaining not only healthy cartilage, but also healthy joint structures, Cosequin is suitable for all dogs and cats that need some joint support, especially highly active or older animals. It adds that the joint care supplement contains 100% pure chondroitin sulphate and the unique formulation has been proven in over 50 clinical trials.
For further information, please contact your local Intervet/Schering-Plough Veterinary Business Manager or phone the company's Veterinary Support Group on 01908 685685.
The case against Jose Ignacio Messa MRCVS related to two heads of charge against him.
The first charge was that, on 13th September 2015, Mr Messa failed to provide adequate and appropriate care to Barney, a border collie. The second charge was that on 14th September 2015 Mr Messa failed to ensure adequate and appropriate on-going care for Barney after his examination of him, including failing to take sufficient steps to ensure that Barney was referred urgently to the care of a referral practice and failing to ensure there were adequate arrangements in place for his ongoing care.
Barney was presented to the Basingstoke practice where Mr Messa was employed having suffered a severe 'stick injury' to his jaw on 12th September.
The Committee heard that, on 13th September, Mr Messa re-examined Barney, administered medication and then discharged him to be cared for at home by his owners. During the examination the owners alerted Mr Messa to the condition of the skin on Barney’s neck, but the Committee heard Mr Messa had felt the area and reassured them it was not something to be concerned about.
The Committee heard that at some point on 13th September, after he was discharged, Barney developed a foetid smell from his mouth caused by an infection and the next day his owners went back to the practice because Barney’s condition had deteriorated – he was unable to walk and had laboured breathing.
On 14th September Mr Messa admitted and sedated Barney and examined him again, noting a hole in the side of his throat that was infected. He recommended referring Barney to a referral practice for further treatment, which was agreed by his owners.
The Committee heard that the referral practice was contacted by a veterinary nurse at the practice and that an appointment for 9am on 15th September 2015 was booked directly with the owner. It also heard that, during his time at Mr Messa’s practice, Barney did not receive intravenous fluids or any further antibiotics.
Barney’s owners said they met with Mr Messa again at around 5pm on 14th September when they came to collect Barney, this was disputed by Mr Messa, and the Committee were not satisfied so as to be sure that it had been Mr Messa who had met the owners and discharged Barney although the Committee found that all the witnesses had been honest and reliable.
Barney was admitted to the referral practice on 15th September but, as a result of sepsis, he suffered a cardiac arrest and died at 10.30pm.
In respect of the first charge the Committee concluded that, on 13th September, Mr Messa made only a rudimentary examination of Barney, and the absence of such basic clinical examination of the temperature, the respiration rate and the pulse of Barney was a failure on the part of Mr Messa and that, furthermore, he did not choose the best course of antibiotic treatment for the wound and infection.
In respect of the second charge Mr Messa admitted that he did not provide fluid therapy to Barney on 14th September before he was discharged.
With reference to the remaining aspects of the charge the Committee took into account the Code of Professional Conduct, particularly in respect of the need for veterinary surgeons to refer cases responsibly and the Code’s supporting guidance on referrals.
The Committee determined that, having delegated the arrangements of the referral to a veterinary nurse, Mr Messa made no attempts to follow up and ensure it was a same-day appointment when this would have better suited the severity of Barney’s condition. The Committee found that he was unaware of Barney’s location or of the time of the appointment and did not make provision for antibiotic or fluid therapy.
Having found the majority of the charges against Mr Messa proven, the Committee then considered whether this amounted to serious professional misconduct.
Disciplinary Committee member Stuart Drummond, who was chairing the Committee and speaking on its behalf, said: "In the light of the facts found proved and considering that disgraceful conduct in a professional respect is that which is conduct falling far below that expected of a veterinary surgeon, the Committee had concluded that the heads of charge, when taken individually, or collectively, do fall below the standard expected.
"However, as a matter of judgement, the Committee did not conclude that Mr Messa’s conduct fell far below the requisite standard and therefore did not amount of disgraceful conduct in a professional respect.
"Whilst the Committee did not find Mr Messa’s actions fell far below the requisite standard, there were concerns expressed about several aspects of this case. There were a number of missed opportunities which occurred; in particular the Committee notes the failure of the care plan and to take adequate steps to ensure that the referral process has been timeously effected."
Petplan has opened nominations for its Petplan Insurance Advisor (PIA) of the Year award.
Available for staff at veterinary practices who are an Appointed Representative (AR) of Petplan, this award recognises PIA's who are dedicated to promoting the benefits of pet insurance in their practice.
Staff can nominate themselves or their colleagues via the website www.petplanvet.co.uk and are encouraged to provide examples of how the nominated PIA has improved practice performance.
The 2012 PIA of the Year will be crowned at the BVNA Congress on 6th October and the winner will receive an iPad. Submissions close on 20th September.
Simon Masding, Petplan Head of Sales and Partnerships said: "This award celebrates the fantastic job our PIAs do communicating the importance of pet insurance to their clients. We know first hand from the time we spend in practice, just how many fun, innovative ways they find to highlight how having insurance helps keep pets healthy."
Virbac has announced the launch of what it describes as an affordable ciclosporin for the treatment of canine atopic dermatitis.
Called Cyclavance, the new product will make its debut at the London Vet Show (Nov 20th/21st at London Olympia).
Cyclavance is presented in a liquid formulation for precise dosing, in a container with a new 'AdaptaCap' designed to ensure leak proof dispensing and give the product a 6 month shelf life after being broached. Cyclavance is offered in four size presentations - 5 ml, 15 ml, 30 ml and 50 ml - to give practices maximum flexibility in its use.
Sarah Walker MRCVS, Product Manager, said: "Atopic dogs present at practices across the country on a daily basis. It is a challenging condition which can be hard to treat successfully because owner compliance is so important. By offering Cyclavance at a great price to give greater appeal, allowing a wider scope of use, and with innovative features, such as the unique AdaptaCap, we aim to help practices achieve better outcomes for their patients and increase the number of clients it is available to.
A research project funded by equine charity The Horse Trust has succeeded in killing equine sarcoid cells in vitro by silencing a gene in the virus that causes sarcoids. The researchers are now hoping to obtain funding for clinical trials using the new technique, which could result in a more effective, non-toxic treatment for sarcoids.
Sarcoids are skin tumors caused by infection with the Bovine Papillomavirus (BPV). They are the most common type of tumour found in horses - the estimated prevalence in the UK is 6-7%. Although the disease is rarely life threatening, many horses with sarcoids are euthanased because the condition is untreatable or because the horse is unsellable. Currently there is no universally effective treatment for sarcoids and if treatment fails the sarcoids will often come back worse.
However, research that was given funding by The Horse Trust offers a potential ray of hope for owners of horses affected by sarcoids. The research was published in Virus Research journal earlier this year.
The research, which was led by Professor Lubna Nasir of the University of Glasgow, found that by inhibiting the activity of a particular viral protein within sarcoid cells, the amount of viral DNA in the cells reduced. This led to a reduction in the growth of the sarcoid cells and caused the cell to die by Programmed cell-death (PCD). The researchers believe that PCD occurs because the sarcoid cells become reliant on the virus.
Professor Nasir said: "This could potentially be a major breakthrough in the treatment of sarcoids. We are now seeking funding to use this technique in clinical trials on horses that have sarcoids."
The research team inhibited the activity of a viral protein called E2, which is needed by BPV to replicate. They used a novel approach termed 'gene silencing' to suppress the activity of the gene that codes the E2 protein. The research was carried out in vitro on fibroblast cells, which had been cultured from sarcoid tissue removed from animals during surgery.
As this research was carried out in vitro, the researchers will now need to see if they can replicate the results in vivo, by developing a way of targeting the sarcoid cells in horses.
"One of the challenges with gene silencing is administering it within clinical setting - as you need to get molecules into every cell. As sarcoids are on the surface of a horse, we think administration should be relatively easy - potentially by injecting or applying a cream to the sarcoid," said Professor Nasir. "If we are able to successfully develop this technique it would be a non-toxic and easy to administer treatment for horses affected by this distressing condition."
Nasir's research could also have an impact on the treatment of lesions in cattle, which are also caused by BPV. Around 50% of cattle in the UK are estimated to have lesions. It may also help with the treatment of Human Papillomavirus (HPV) infections in humans. HPV, which is similar to BPV, can lead to various cancers in humans including cervical and vaginal cancer.
Paul Jepson, Chief Executive and Veterinary Director of The Horse Trust said: "We are really excited that the research we have funded could lead to a major breakthrough in the treatment of sarcoids."
RIP Fleas, the environmental flea treatment from Genitrix, has been given a new formulation to ensure it acts more quickly in the killing of adult fleas and that it continues to kill fleas as they emerge from pupae for up to 12 months.
Now known as RIP Fleas Extra, the product is also licensed for the control of house dust mites in the environment for up to 12 months.
According to Genitrix, the reformulation makes RIP Fleas Extra the only environmental flea treatment to contain three active ingredients while complying fully with new EU Biocides regulations. It is the only such treatment to be fragranced and is also the only product to be presented in a volume which will cover 120 square metres - ie the size of an average house.
RIP Fleas Extra contains:
When used synergistically, Tetramethrin and Permethrin provide a rapid knockdown and kill of fleas as they hatch from pupae. Studies have shown that this combination works four times more quickly than Permethrin alone.
Dr Westwood, who now lives in Australia, had been referred to the Committee in relation to a number of charges against him relating to the treatment of a cat at his former practice in Cardiff in October 2015.
He was not present at the inquiry and had requested that his solicitor, Tony Wilson, act on his behalf.
Mr Wilson made an application to the Committee that the hearing should be adjourned contingent on a form of undertakings being accepted. These undertakings were that Dr Westwood’s name be removed from the Register with immediate effect and that he never apply to be restored to the Register under any category.
The application was granted by the Committee, taking into account a number of factors. These included the fact that Dr Westwood has retired as a veterinary surgeon, that he has closed his practice and returned to his home in Australia with no intention of returning to the UK, and that animal welfare and the reputation of the profession have been protected as Dr Westwood will no longer be in practice.
The Committee noted that there were several precedents for concluding cases in such a manner, and that the application was not objected to by the complainant or opposed by the College.
Dr Westwood’s name was removed from the Register of Veterinary Surgeons with immediate effect as of Monday 14 August 2017.
Vétoquinol - maker of Epiphen, the anti-epileptic phenobarbital for the control of epilepsy in dogs - has added a new client brochure and a fridge magnet to its Epiphen support packs, designed to help owners understand the condition and make it easier for them to comply with daily dosage requirements.
The new brochure is called What I need to know and is written for clients that have been prescribed Epiphen for their pet for the first time.
Abbie King, Product Manager for Epiphen, said: ''The inspiration for the new brochure came after spending time at the Animal Health Trust in Newmarket and realising how much information an owner needs to take in when their dog is diagnosed with epilepsy."
The new brochure covers the important information owners need to help them understand and manage their dog's epilepsy, including how Epiphen works, what they can do to help their dog, how to monitor seizures, where to find further information and frequently asked questions.
The Epiphen Treatment fridge magnet is designed as a quick reference guide to prescribing information that is needed every day when living with a dog with epilepsy. The magnet leaves space for the owner to write in their dog's name, dosage details and timings and their vet's phone number. Vétoquinol says it is especially helpful as a reference if more than one person is caring for the dog.
The new items enhance the existing Epiphen support pack, which comprises an owner manual, medication record and seizure diary, dog tags, seizure report pads, free serum level monitoring vouchers and a free, online resource at www.epiphenonline.co.uk
Vétoquinol also invites practitioners who are dealing with challenging cases to take advantage of its free Ask the expert scheme on 0800 169 8197 or email a case history to epiphen@vetoquinol.co.uk.
To order the new Epiphen support materials, ring 0800 1698197. Alternatively, visit: www.vetoquinol.co.uk to find out more.
The Veterinary Benevolent Fund has launched a short film about a veterinary surgeon's experience of severe depression and her inspiring recovery.
The charity says it hopes the film, published on the Vetlife website today, will encourage the veterinary profession to talk more openly about stress and depression in the workplace and will motivate veterinary employers to adopt best practice in supporting their staff's mental health.
Nick Short, the VBF Director responsible for the development of the Vetlife website, said: "We are so grateful to the veterinary surgeon concerned for having the courage to share her story and for her insights into what could be done to make recovery easier for other vets. We were delighted to hear that she felt she was treated well and got the help she needed from the Veterinary Benevolent Fund and the Veterinary Surgeons' Health Support Programme.
"Recent press reports have estimated that the cost to the UK economy of stress, depression and suicide is £26 billion per year. We know that the profession has a high incidence of these problems, so it follows that depressive illness must have an alarming economic effect on it. This means it is essential to invest in improving awareness and support.
"The VBF wants to produce more web videos on issues that veterinary surgeons, students or nurses commonly encounter such as debt, addiction, professional conduct or employment problems. However, we need to secure additional sponsorship in order to fund this work - each 5 minute video will cost about £2,500 to produce. If you or your organization would be interested in supporting this work, please contact the VBF office at 7 Mansfield Street, London W1G 9NQ, telephone 020 7908 6385 or email info@vetlife.org.uk. Donations can also be made online at www.justgiving.com/VBF"
Rory O'Connor, National Co-ordinator at the Veterinary Surgeons' Health Support Programme said: "Many of us will have mental health problems at some point in our lives but most can make a full return to work with the right support. As highlighted in the film, it is really helpful if employers are willing to explore adjustments to working conditions or to the working environment such as flexible working hours or changes to working responsibilities. I am always available to help both employers and employees with these kinds of discussions and we are currently developing content on mental health support in the workplace for the Vetlife website. All advice is completely confidential."
The film was made by John Somers and Ben Sheriff at the University of Exeter using an actress to speak the words of the veterinary surgeon.
Veterinary nurses, veterinary surgeons, students and other veterinary professionals are all invited to take part in the anonymous survey and share incidents where they have witnessed discrimination or felt discriminated against.
The survey covers the nine protected characteristics under the Equality Act: age, gender reassignment, marital or partnership status, being pregnant, disability, race, religion, sex and sexual orientation. It also includes other forms of discrimination which might not fit under these characteristics, such as body weight and socio-economic background.
BVA Junior Vice President Daniella Dos Santos said: "The veterinary professions should be open, welcoming and supportive of everyone; however, it is clear from the reports we’re hearing that discrimination is still an issue. Worse still, we’re aware that some colleagues have faced a backlash when talking about their experiences of discrimination. This is completely unacceptable.
"If we hope to prompt meaningful change we need to fully understand the scale of the problems our colleagues are facing. To do that it’s important that we provide a safe, anonymous space for everyone to share their experiences. We hope this questionnaire will give people that opportunity and we would like to sincerely thank our colleagues for their willingness to share their personal experiences with us."
The survey was developed with the support of the British Veterinary Ethnicity and Diversity Society (BVEDS) and British Veterinary LGBT+.
BVA says it intends to gather further quantitative data on discrimination via its Spring Voice of the Veterinary Profession Survey 2019.
The questionnaire is open from 2 February until 2 March and should take around 10 minutes to complete. A link to the questionnaire is available here.
Ceva Animal Health has announced the winners of it's firework waiting room display competition which, according to the company, had a record-breaking number of entries submitted this year.
To enter the competition, practices had to create an eye-catching display to help educate owners on firework fears in pets and how to prepare them for firework season with the help of pheromone products Feliway for cats and DAP for dogs. Ceva supplied entrants with marketing materials featuring Ceva's animated characters 'That Purple Cat' and 'Dap The Dog' from the company's TV advertising and marketing campaign.
South Beech Veterinary Surgery, Essex, Broadleys Veterinary Hospital, Stirling and The Avenue Veterinary Clinic in Ealing were the three winners, and each receive a pizza lunch for the whole practice to enjoy.
Rachel Levy, marketing support manager for Ceva said: "As always we received some fantastic entries and it was so hard to choose the winners. We would like to thank everyone who entered for their continued support and hard work in creating the displays.''
For further information on DAP and Feliway, visit www.secrettohappypets.com.
Vets and vet nurses are being asked to take part in a survey which aims to help the industry get a better understanding of canine reproduction health issues.
The survey is being conducted by Virbac Animal Health as part of its reproductive health awareness campaign.
Product manager Chris Geddes MRCVS said: "Following a series of CPD seminars on reproduction, it is evident that the views and experiences of vets vary considerably when it comes to companion animal sexual health.
"The aim of the survey is to obtain a clearer picture of the thoughts and experiences of vets and VNs on the neutering of dogs in the UK. The questionnaire will help us gain a better understanding of practice needs in this often sensitive area, and help provide improved support for vets and pet owners alike.
"Whilst attitudes on neutering vary from country to another, it is clear that within the UK, opinion among vets and pet owners is wider than perhaps we currently realise. The UK currently has the highest canine male and female neutering rate in Europe. What this means will depend on your viewpoint and experiences, however we know that some practices are beginning to offer clients a wider range of options."
He added: "As a veterinary-focused business our aim is to provide solutions which will help support and develop the relationship between practice and client. This survey is part of that continuing process."
All those completing the questionnaire will receive a Cadbury's chocolate bar for taking part, with one lucky person winning £250.00 of M&S vouchers.
If you would like to take part please visit http://www.virbacsurvey.animaloracle.com/
Boehringer Ingelheim Vetmedica has launched Benefortin (benazepril hydrochloride), an ACE inhibitor licensed for the treatment of congestive heart failure (CHF) in dogs. It is also licensed for the treatment of chronic renal insufficiency (CRI) in cats.
Benefortin uses novel micro-cap technology to mask the taste of the bitter molecule. According to Boehringer, this ensures that Benefortin tastes good1, even if it is bitten, crunched or chewed. The company says taste tests demonstrated 100% palatability in dogs and 92% palatability in cats in home settings1.
Benefortin is available in 5mg and 20mg tablets for dogs and 2.5mg tablets for cats and dogs.
Jemima Scott, Boehringer Ingelheim brand manager said: "The addition of Benefortin to our cardiology portfolio now enables us to provide veterinary practices with two of the cornerstones of canine CHF treatment, and the palatability of Benefortin makes it an excellent choice for vets needing to prescribe an ACE inhibitor."
To support the launch of Benefortin, Boehringer is offering veterinary practices the opportunity to win one of three Bosch microwave ovens in a prize draw by answering three multiple choice questions on the ACE inhibitor.
For further information on Benefortin, contact your local Boehringer Ingelheim Vetmedica territory manager or telephone 01344 746959.
Remote consultations and prescribing have been the subject of much debate in the profession of late. A motion to conduct a trial of prescribing without a physical examination was considered by the RCVS Council in November, when a large number of serious concerns were raised.
However, none of those concerns related to the provision of remote consulting services for existing clients with animals who are already under the care of the veterinary surgeon. That's where systems like this could add real value to the service offered by veterinary practices.
George Kyriacou, Director at VVG said: "Telemedicine is happening, and it’s happening in a big way. Virtual consultations are becoming more and more popular with pet owners who are not really sure if they need to see a vet and would simply like some reassurance.
"An option to have a qualified vet in your pocket at anytime of the day is attractive. However, the option to have a convenient consultation with your own trusted vet is the holy grail."
The system allows those practices who wish to charge for online consults to take payment online. Some, however, offer free consultations, in particular post-op, because it saves everyone time.
VVG points out that the system can also be used to deliver nursing consultations, too.
Simon Power, Commercial Manager at Vets One referrals in Crimplesham, Norfolk said: "Since adopting the system we have had a number of post-op and medication reviews virtually; it not only saves us a consulting room but also allows our clients to have the expert advice our team provide from the comfort of their own home."
VVG costs £249 to set up, plus from £59 per month thereafter, per practice.
For more information, contact George Kyriacou at George@thevvg.com or call 01842558022.
Virbac has announced the launch of My Virbac, a new website offering a range of business, marketing and technical services for veterinary professionals.
The main elements of My Virbac are:
Virbac Product Manager, Ms Victoria Hudson said: "Virbac was one of the pioneers of the concept of practice support and the services we already offer are highly valued by our customers. In developing My Virbac, we're taking things to a new level. We've worked with business and veterinary experts to develop a practical and helpful range of services which will make a real difference to practices that use them. We plan to add additional services and tools on a regular basis.
"As the veterinary sector becomes increasingly competitive, providing an outstanding clinical service is no longer enough. Practices must also be well-run businesses, with a strong focus on marketing and client retention. Taking advantage of the services and tools available on My Virbac will help practices to ensure they are well placed to succeed even in difficult times."
To access Virbac's services platform, practices and individuals can register at www.my-virbac.co.uk.
The International Society of Feline Medicine (ISFM) has published 'Consensus Guidelines on the Long-term use of NSAIDs in cats' in the July 2010 edition of the Journal of Feline Medicine and Surgery.
The society says it has developed the guidelines in order to try and address the major welfare issue of cats suffering unremitting and untreated chronic pain. Until recently, NSAIDs had only been licensed for short-term use in cats, but with changing licensing indications and recommendations, they are now also increasingly used for long-term treatment of cats, for example in the management of osteoarthritis.
However, in most cases where long-term use of pain relief in cats is required, there are concomitant problems with other diseases or other drugs that are being given. According to the ISFM, one of the most common concerns is whether NSAIDs can be used to treat arthritis in older cats with kidney disease. The society says that because of concerns like these, and the potential for adverse effects, cats often receive no treatment at all, and their quality of life can be severely compromised.
For this reason, the ISFM set up an international expert panel to develop practical and rational guidelines on the long-term use of NSAIDs in cats. The aim was to provide guidelines that would empower clinicians, enabling them to make sensible and rational choices, and ensure much-needed therapy is not needlessly withheld from patients.
The panel was made up of Andrew Sparkes, Duncan Lascelles, Richard Malik, Sheilah Robertson, Margie Scherk, Polly Taylor, Llibertat Real Sampietro and Reidun Heiene.
Along with the veterinary information in the guidelines, the panel also developed a brief client-facing leaflet that can be given to owners when NSAIDs are prescribed for their cats - this leaflet provides simple, clear advice on why NSAIDs are used, why they are important, but also what simple precautions avoid adverse effects, with further advice on when to seek veterinary advice to reinforce the safety message.
Both of these publications are available to download from the website www.isfm.net/toolbox
Medivet is celebrating its 100th batch collection for Vet Blood Supplies, the north London-based bloodbank set up in 2007 to provide blood products for its branches around the country.
Veterinary nurse Laura Brind, who is responsible for collecting the blood, said: "We are really proud to celebrate the 100th collection. We travel to Retired Greyhound Trust kennels across south-east England who kindly agreed to arrange the donation in return for free preventative treatment for the dogs."
The collection was taken from Barn Kennels, the Portsmouth branch of the Retired Greyhound Trust, which has been donating blood for the past 18 months.
Novartis Animal Health's year long campaign to drive pet-owner awareness of the importance of worming pets regularly got off to a rather damp start in London today, with 63 people in doggy suits - mostly company employees I gather - running around the capital accompanied by two 'pooch vans'.
The 'Worm Patrol' team will be visiting veterinary practices over the summer to help promote, set up and run Pet Worming Awareness Days and attend practice open days. Veterinary practitioners will have access to the Worm Patrol support kit including the branded pooch van, Chewy the dog mascot and a worm patrol ambassador. Additional support will include educational leaflets for owners, giveaways and waiting room materials.
Maggie Fisher, Chairperson of the European Scientific Counsel for Companion Animal Parasites is backing the campaign. She said: "Raising awareness of worm control throughout the life of cats and dogs is important, particularly when it is reported that 80 percent of children kiss their pet and 21 percent let them lick their fingers after sharing food. While the risk may be relatively low, the consequences can be serious, especially in children.
"It's important that pet owners take responsibility for their animals and we are pleased that initiatives such as the Worm Patrol and 'Pet Worming Awareness Days' will help practices highlight the risk that endoparasites pose to humans and companion animals in a novel and light-hearted way."
To arrange for the Worm Patrol to visit to your practice, or for further information about setting up a Pet Awareness Worming Day, please contact your Novartis Animal Health Territory Manager or Novartis Animal Health UK Ltd on +44 (0)1276 694402.
The BVA has responded to the Written Ministerial Statement from the Defra Secretary of State at the end of the licence for badger culling in Somerset.
BVA President Robin Hargreaves said: "The British Veterinary Association (BVA) has supported the pilot culls in England to determine whether badger culling can be delivered humanely, effectively, and safely by controlled shooting.
"We will not prejudge the report of the Independent Expert Panel (IEP), which will consider data from the initial 6-week pilots in Somerset and Gloucestershire, but we are interested to note the Secretary of State's announcement that current indications suggest that the pilot has been safe and humane.
"Today our Veterinary Policy Group has discussed the issues surrounding the extensions to the licences. We agree with the Chief Veterinary Officer's advice that extensions in order to remove a greater number of badgers and get closer to achieving the 70% rate of the Randomised Badger Culling Trials (RBCTs) are justified to improve the bovine TB disease situation and mitigate the potential impact of badger perturbation.
"Following questions raised by our members we have been assured by Defra that monitoring of the culling will continue to ensure it is being carried out in accordance with the humaneness and safety stipulations in the licences. Although it is important to note that this data will not form part of the information being considered by the IEP.
"We await the report of the IEP and will engage members in considering what impact it will have on the overall bovine TB eradication strategy for England."
According to the AHT, there is undisputed evidence that owners, riders and trainers have a poor ability to recognise signs of pain seen when horses are ridden. As a result, problems are labelled as training-related, rider-related, behavioural, or deemed 'normal' for that horse because 'that’s how he’s always gone'.
This, says the AHT, means pain-related problems are often disregarded, the horse continues in work, and the problem gets progressively worse.
Dr Sue Dyson, Head of Clinical Orthopaedics at the AHT, believes it may be easier to educate riders and trainers to recognise changes in facial expression and behaviour rather than lameness. So she and her team set out to develop and test an ethogram to describe facial expressions in ridden horses and to determine whether individuals could interpret and correctly apply the ethogram consistently.
At this stage in the project, they concluded that their ethogram could reliably be used to describe facial expressions of ridden horses by people from different professional backgrounds (full paper here: http://www.journalvetbehavior.com/article/S1558-7878(16)30184-8/fulltext).
In the next stage of the project, Sue and her team sought to demonstrate that the ethogram could be used to identify lameness.
The ethogram was applied blindly by a trained analyst to photographs (n=519) of the head and neck of lame (n=76) and non-lame (n=25) horses acquired during ridden schooling-type work at both trot and canter. These included images of seven lame horses acquired before (n=30 photographs) and after diagnostic analgesia had abolished lameness (n=22 photographs).
A pain score (0-3; 0=normal, 1-3=abnormal) was applied to each feature in the ethogram, based on published descriptions of pain in horses.
A total of 27,407 facial markers were recorded, with those giving the greatest significant difference between lame and sound horses including ears back, eyes partially or fully closed, an open mouth with exposed teeth and being severely above the bit.
Pain scores were higher for lame horses than non-lame horses (p<0.001). Total pain score (p<0.05), total head position score (p<0.01), and total ear score (p<0.01) were reduced in lame horses after abolition of lameness.
Severely ‘above the bit’, twisting the head, asymmetrical position of the bit, ear position (both ears backwards, one ear backwards and one to the side, one ear backwards and one ear forwards) and eye features (exposure of the sclera, the eye partially or completely closed, muscle tension caudal to the eye, an intense stare) were the best indicators of pain.
The researchers concluded that application of the ethogram and pain score could differentiate between lame and non-lame horses. Assessment of facial expression could potentially improve recognition of pain-related gait abnormalities in ridden horses (full paper here: http://www.journalvetbehavior.com/article/S1558-7878(17)30019-9/fulltext)
Sue and her team are now working on the development of a whole horse ethogram and its application to non-lame and lame horses, to help to differentiate between manifestations of conflict behaviour, in response to the demands of the rider, and pain. They are also working towards the development of a practical tool for recognising facial expressions, similar to that of a body condition score chart, which they say could dramatically improve the health and welfare of all horses.
Photo: Signs of pain include ears back (pain score of 3), intense stare, muscle tension and mouth. Courtesy Dr Sue Tyson.
A group of brave veterinary nurses and a student nurse leapt out of a perfectly serviceable aircraft last weekend, both to raise money for children with epilepsy, and to highlight the need to protect the title 'Veterinary Nurse' in law.
Vicky Couzens, Jenny Cook, Kim Blowing, Michelle Dickens, Gillian James and Leigh Martin, none of whom had parachuted before (in fact, Gillian hadn't even been in a plane before), were raising money for the Muir Maxwell Trust, a charity which funds research into childhood epilepsy, and supports the families of some of the 70,000 children affected by it in the UK.
The daredevil nurses also wanted to highlight the fact that anyone can call themselves a veterinary nurse, regardless of whether they've ever even set foot inside a veterinary practice, let alone passed the demanding examinations. They argue that the title 'Veterinary Nurse' should be protected in law, in exactly the same way as 'Veterinary Surgeon', so that the pet-owning public can have the reassurance of knowing when their animal is being cared for by a qualified professional.
To support these nurses' efforts, and help them reach their fundraising targets, click the links below:
http://www.justgiving.com/Victoria-Couzens http://www.justgiving.com/Jenny-Cook23 http://www.justgiving.com/KimBlowing http://www.justgiving.com/Michelle-Dickens
Meanwhile, one of the children that has benefitted from the work done by the Muir Maxwell Trust is Emily Guthrie, daughter of the editor of VetNurse.co.uk and VetSurgeon.org. She sent the jumpers her own message of thanks:
watch?v=jI90GdmIUGk